RTA.vc
VC Fund
Warszawa, Poland
RTA.vc is a VC fund in Warszawa focused on Health Care and Software. RTA.vc invests early in online businesses with special focus on healthcare related products and business models like SaaS (software as a service) and marketplaces. RTA.vc is managed by Piotr Kulesza and Lubomir Jurczak and is based in Berlin, Germany and in Warsaw, Poland. The largest investments include Docplanner, Typeform, Point Nine Capital.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 12%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries RTA.vc invests in
Stages RTA.vc invests in
Countries RTA.vc invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $590k–$2.4M
- Series A
- $1M–$9.2M
- Series B
- $10M–$13M
Investment Focus
Industry
- Health Care 8 (20%)
- Software 6 (15%)
- Artificial Intelligence 6 (15%)
- SaaS 3 (7%)
- Internet 3 (7%)
Stage
- Seed 14 (34%)
- Series A 12 (29%)
- Series B 2 (5%)
- Venture - Series Unknown 2 (5%)
- Pre-Seed 1 (2%)
Country
- Poland 8 (20%)
- United States 8 (20%)
- France 2 (5%)
- Germany 2 (5%)
- Slovenia 2 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Piotr Kulesza
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 7 | Find email | |
Lubomir Jurczak
Founder and Partner
|
Founder and Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AlohaCamp is an online booking portal for adventure travel. They offer tent, campervan, glamping, and cottage sites. It provides a referral program. | Seed / Oct 14, 2022 | ||
| MNM is a scientific start-up created by an interdisciplinary group of enthusiasts. We are a multi-specialist team of experts from geneticists, to molecular biologists, bioinformaticians and AI specialists. We combine next-generation AI with the most advanced genomic approaches (whole genome and multiomics data) to save the lives of cancer patientsthrough predictive modeling and drug target identification. | $2.4M / Seed / Oct 20, 2020 | ||
| MNM has built a technology to rank cancer treatment based on molecular features of a tumor sample. AI heavy, the software analyses 100% of tumor genomic information (traditionally <0.1% is used) and by extracting “biomarker signatures” from individual tumor, matches it with the collection of biomarker signatures developed for each individualtherapies. It results in a ranking of most likely effective cancer therapies. The technology also allows for novel target identification. | $590K / Seed / Jan 21, 2020 | ||
| MNM is a scientific start-up created by an interdisciplinary group of enthusiasts. We are a multi-specialist team of experts from geneticists, to molecular biologists, bioinformaticians and AI specialists. We combine next-generation AI with the most advanced genomic approaches (whole genome and multiomics data) to save the lives of cancer patientsthrough predictive modeling and drug target identification. | $590K / Seed / Jan 21, 2020 | ||
| Cardiomatics offers cutting-edge, cloud AI-based digital analysis of ECG data. It is a medical-grade system, based on accurate algorithms, ensuring high-quality and trusted outcomes. As a digital health technology developer, Cardiomatics cooperates with physicians, manufacturers, and providers of ECG devices globally. | $304.6K / Pre-Seed / Jul 12, 2019 | ||
| Preply is a provider of an online tutoring marketplace intended to promote faster learning with one-on-one online tutors. The company's marketplace helps to find and book professional private tutors online from over 185 countries, enabling users to achieve their goals and speak confidently. | $4M / Seed / Jul 24, 2018 | ||
| Booksy is the largest and fastest growing booking platform that connects beauty, wellness and health professionals with local customers, powering hundreds of millions of appointments each year.Booksy Biz, designed specifically for small business owners, is Boosky’s mobile-first SaaS platform that combines all the tools providers need to attractnew customers, take appointments, manage staff and payments, and build a loyal client base. The Booksy Marketplace is where millions of consumers around the world find, schedule and manage appointments with stylists, barbers, braiders, nail artists, estheticians, massage therapists, salons, and spas in their communities. Customers can browse business profiles, reviews, services, pricing, availability and instantly book appointments with the click of a button. Founded in Poland in 2014, Booksy has operations in Poland, United States, United Kingdom, Spain and France. The company has raised more than $100M in Series C funding and is backed by investors including Inovia, Kaya, and Verdane. Learn more at booksy.com. | $13.2M / Series B / Jul 05, 2018 | ||
| Eversports vision is to simplify the access to sport facilities in your environment. They thrive to build a unique community of sporters and to share their passion around the globe. Eversports connects its members directly with sport venues, helps them to book courts or courses and to meet sport partners. With Eversports you know exactly where andwhen to practice your favourite sport. Find all the information you need in one single interface. Eversports is the marketplace where sport providers and sporters get easily connected. | $6M / Series A / May 03, 2018 | ||
| Apptopia provides services in app analytics, data mining and business intelligence for the mobile industry. Through its main platform called Insights, it uses Big data technologies to collect, measure, analyze and provide user engagement statistics for mobile apps.The company was launched in 2012 and by May of 2014 has already reached $5m inannual run rate. | Series A / Apr 02, 2018 | ||
| Lifen is a 160-person startup, based in Paris, whose ambition is to facilitate the deployment of digital solutions for hospitals, doctors and patients. Since 2015, Lifen has been simplifying the sharing of medical data and has quickly established itself as the leading MSSanté operator in France with more than 600 partner establishments. Everymonth, Lifen sends 2 million medical documents to 240,000 doctors. Creator of the FHIR France meetup and winner of the ANS interoperability prize 2020, Lifen's ambition is to use its expertise in interoperability with HIS to develop a platform that radically simplifies the technical integration and operational deployment of all types of digital solutions. | $9.2M / Series A / Mar 08, 2018 | ||
| See all 41 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does RTA.vc invest in?
RTA.vc invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 41 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does RTA.vc invest in?
RTA.vc typically joins rounds of $590k–$2.4M at Seed, $1M–$9.2M at Series A and $10M–$13M at Series B. These are whole funding-round sizes, not RTA.vc's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds RTA.vc took part in.
How do I contact RTA.vc?
Public channels for RTA.vc include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at RTA.vc?
The team at RTA.vc includes Piotr Kulesza (Founder and Managing Partner) and Lubomir Jurczak (Founder and Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
